Alumis Statistics
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.96-0.37 (-8.55%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Alumis by the numbers
Alumis has a market capitalization of $514.1 million based on 129.82M shares outstanding. With trailing EPS of $-3.53, Alumis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.8% below its 50-day average and 80.1% below its 200-day average.
Average daily trading volume is 2.87M shares, or about $11.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALMS valuation vs. peer median
| Metric | ALMS | Peer median | Difference |
|---|---|---|---|
| Market cap | $514.09M | $541.51M | -5% |
| Avg. volume | 2.87M | 1.37M | +109% |
Peer median across 8 companies: ZVRA, WVE, CLYM, HELP, CBIO, AVBP, ACRS, ANL.
Valuation
- Market cap
- $514.09M
- Price / sales (latest FY)
- 21.38
- EPS (TTM)
- $-3.53
- Shares outstanding
- 129.82M
Price and trading
- Previous close
- 4.33
- Open
- 4.24
- Day range
- 3.94 – 4.36
- 52-week range
- 3.94 – 31.35
- 52-week change
- -45.75%
- Beta
- —
- Volume
- 1.79M
- Average volume
- 2.87M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 514.09M
- Forward Pe
- -1.36
- Eps
- -3.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.35
- Week52 Low
- 3.94
- Avg Volume
- 2.87M
- Shares Outstanding
- 129.82M
- Ma50
- 6.69
- Ma200
- 19.90
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -87.37%
- Pct From52w Low
- 0.64%